Embracing China 2.0: AZ, Merck KGaA Set Up Funds, J&J Steps Up Digital Push

 
• By Brian Yang

AstraZeneca has pledged $1bn to a healthcare fund to support local innovation in China, joining big pharma peers J&J and Merck KGaA in fresh moves to embrace this market, where a new wave of digital technology transformation and fast-shifting trends now favor novel new therapies and the rise of local health start-ups

Shanghai overpass
ASTRAZENECA TO SET UP GLOBAL R&D AND AI CENTER IN SHANGHAI • Source: Shutterstock

More from China

More from Focus On Asia